Evolution of PDE5 inhibitors in Korea

来源 :华夏医学论坛·泌尿生殖2015暨亚太性医学年会2015 | 被引量 : 0次 | 上传用户:zhang1118168
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  After launching of Sildenafil Citrate,the last invention of 20th century,in 1998,oral PDE5 inhibitor has been established as first line treatment of erectile dysfunction(ED)and shift new paradigm of diagnosis and treatment of ED.The big success of sildenafil in pharmaceutical R&D induced the consecutive development of the so-calledThe second viagra,e.g.,Tadalafil and Vardenafil in 2003.Currently,these 3 kinds of PDE5 inhibitors are most famous and well-known PDE5 inhibitors worldwide.In Korea,another 3 kinds of PDE5 inhibitors,Udenafil(2005),Mirodenafil(2007)and Avanafil(2011)have been developed and 6 kinds of PDE5 inhibitors were used in the competitive market.In last 10 years,the evolution of PDE5 inhibitors competition has changed the dosage concept from on-demand to daily low-dose and applied for other indications beyond ED such as pulmonary hypertension in Sildenafil,and BPH/LUTS in Tadalafil and penile rehabilitation with daily low dose.For the preparations of PDE5 inhibitors,the termination of Korean patent of sildenafil in 2012 released 4 preparations of PDE5 inhibitors,tablet,oro-disposable film,granule and chewable of 60 generic Sildenafil from 49 companies.The orodisposable film and chewable are favorable from patients.In Korea,patent of Cialis will be terminated in near future and the development of generic drugs like Viagra will go in the right way and as expected.The long half-life of Tadalafil enabled the approval for BPH/LUTS with daily low dose usage.In turn,the generic Cialis also will be developed as various preparations including oro-disposable film and as combination with antihypertensive for ED/HT,PDE5 inhibitor with alpha blockers for ED/LUTS and PDE5 inhibitor with antidepressant for ED/PE.The present lecture review the evolution of PDE5 inhibitors from the development of sildenafil citrate in 1998 to combination in 2015,Korea.
其他文献
Objective: To describe sexual function of women in the late postmenopause and to investigate change from early postmenopause.Methods: Cross sectional analysis of 2012/13 and longitudinal analysis from
Impression management for men aiming at courtship and love is cognitively taxing and is costly.Recent research suggests that when a man tries to impress an attractive woman his cognitive performance c
Objective: Generally speaking,historically,two main types of surgical treatments have been used to straighten penis deformity in Peyronies disease(PD)*: viz.(Ⅰ)plication procedures;and(Ⅱ)assorted graf
Penile augmentation surgical procedure includes diverse graft materials such as artificial collagen material as well as dermo-fat graft.Important factors of postoperative satisfaction are natural appe
Background and Objective: Erectile dysfunction(ED),or male impotence,is defined as the consistent inability to achieve and/or maintain an erection sufficient for satisfactory sexual activity,according
Peyronie disease can be physically and psychologically devastating for subjects and their partners.Collagenase Clostridium histolyticum(CCh),a purified mixture of AUX-I and II collagenases,is an intra
Objective: To describe the surgical technique and initial experience of laparoscopic radical cystectomy and intracorporeal orthotopic ileal neobladder with bilateral isoperistaltic afferent limbs.Mate
Objective: We introduce the innovative Institute of Urology,Peking University(IUPU)techniques for retroperitoneal laparoscopic surgery for the upper urinary tract,which have been published by Departme
Objective: To evaluate the results of nocturnal penile erection test and response to daily sildenafil in patients with erectile dysfunction(ED)due to pelvic fracture urethral disruption.Methods: In th
Objective: To research the prevalence of erectile dysfunction(ED)and the influencial factors in male renal transplant recipients(RTR).Methods: A cross-sectional survey was conducted in three renal tra